{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T13:58:35Z","timestamp":1788184715071,"version":"build-2803163510"},"reference-count":50,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Revue Neurologique"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1016\/j.neurol.2010.08.004","type":"journal-article","created":{"date-parts":[[2010,11,14]],"date-time":"2010-11-14T04:16:53Z","timestamp":1289708213000},"page":"987-997","source":"Crossref","is-referenced-by-count":5,"title":["Myasth\u00e9nies oculaires\u00a0: diagnostic et traitement"],"prefix":"10.1016","volume":"166","author":[{"given":"T.","family":"Stojkovic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"B\u00e9hin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurol.2010.08.004_bib0005","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1055\/s-2000-6829","article-title":"Ocular aspects of myasthenia gravis","volume":"20","author":"Barton","year":"2000","journal-title":"Semin Neurol"},{"key":"10.1016\/j.neurol.2010.08.004_bib0010","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1212\/01.wnl.0000327669.75695.38","article-title":"Treatment of ocular symptoms in myasthenia gravis","volume":"71","author":"Bhanushali","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2010.08.004_bib0015","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.nmd.2006.05.006","article-title":"A systematic review of diagnostic studies in myasthenia gravis","volume":"16","author":"Benatar","year":"2006","journal-title":"Neuromusc Disord"},{"key":"10.1016\/j.neurol.2010.08.004_bib0020","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1212\/01.wnl.0000263481.14289.90","article-title":"Evidence report: the medical treatment of ocular myasthenia (an evidence-based review)","volume":"68","author":"Benatar","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2010.08.004_bib0025","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1002\/ana.410140504","article-title":"Prognosis of ocular myasthenia","volume":"14","author":"Bever","year":"1983","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neurol.2010.08.004_bib0030","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1001\/archneur.62.6.1002","article-title":"Anti-MuSK myasthenia gravis presenting with purely ocular findings","volume":"62","author":"Caress","year":"2005","journal-title":"Arch Neurol"},{"key":"10.1016\/j.neurol.2010.08.004_bib0035","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1136\/bjo.2006.108498","article-title":"Ocular myasthenia: a rare presentation with MuSk antibody and bilateral extraocular muscle atrophy","volume":"91","author":"Chan","year":"2007","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.neurol.2010.08.004_bib0040","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1007\/s00415-008-0718-9","article-title":"Mycophenolate mofetil for ocular myasthenia","volume":"255","author":"Chan","year":"2008","journal-title":"J Neurol"},{"key":"10.1016\/j.neurol.2010.08.004_bib0045","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1002\/mus.21195","article-title":"Juvenile myasthenia gravis","volume":"39","author":"Chiang","year":"2009","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.neurol.2010.08.004_bib0050","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1212\/WNL.43.9.1779","article-title":"Incidence and prevalence of myasthenia gravis in western Denmark 1975\u00a0to 1989","volume":"43","author":"Christensen","year":"1993","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2010.08.004_bib0055","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1001\/archneur.1986.00520080081029","article-title":"The office Tensilon test for myasthenia gravis","volume":"43","author":"Daroff","year":"1986","journal-title":"Arch Neurol"},{"key":"10.1016\/j.neurol.2010.08.004_bib0060","first-page":"271","article-title":"Extraocular muscles responses to orbital cooling (ice test) for ocular myasthenia gravis diagnosis","volume":"4","author":"Ellis","year":"2000","journal-title":"JAAPOS"},{"key":"10.1016\/j.neurol.2010.08.004_bib0065","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1600-0404.1988.tb06970.x","article-title":"Ocular myasthenia: diagnostic and therapeutic problems","volume":"77","author":"Evoli","year":"1988","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.neurol.2010.08.004_bib0070","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1002\/mus.21156","article-title":"Correlating extent of neuromuscular instability with acetylcholine receptor antibodies","volume":"39","author":"Farrugia","year":"2009","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.neurol.2010.08.004_bib0075","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1152\/physiolgenomics.00115.2001","article-title":"Expression profiling reveals metbolic and structural components of extraocular muscles","volume":"9","author":"Fischer","year":"2002","journal-title":"Physiol Genomics"},{"key":"10.1016\/j.neurol.2010.08.004_bib0080","doi-asserted-by":"crossref","first-page":"3828","DOI":"10.1167\/iovs.06-0073","article-title":"Identification of acetylcholine receptors subunits differentially expressed in singly and multiply innervated fibers of extraocular muscles","volume":"47","author":"Fraterman","year":"2006","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.neurol.2010.08.004_bib0085","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/IIO.0b013e31815726f5","article-title":"Ocular myasthenia gravis","volume":"47","author":"Gilbert","year":"2007","journal-title":"Int J Ophtalmol Clin"},{"key":"10.1016\/j.neurol.2010.08.004_bib0090","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1001\/archneur.64.12.1790","article-title":"Ocular myasthenia treatment, the case against prednisone therapy and thymectomy","volume":"64","author":"Gilbert","year":"2007","journal-title":"Arch Neurol"},{"key":"10.1016\/j.neurol.2010.08.004_bib0095","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1016\/S0161-6420(99)00709-5","article-title":"An ice test for the diagnosis of myasthenia gravis","volume":"106","author":"Golnik","year":"1999","journal-title":"Ophthalmology"},{"key":"10.1016\/j.neurol.2010.08.004_bib0100","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/ejhg.2009.10","article-title":"Improving pharmacovigilance in Europe: TPMT genotyping and phenotyping in the UK and Spain","volume":"17","author":"Gurwitz","year":"2009","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.neurol.2010.08.004_bib0105","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jns.2008.05.023","article-title":"Prognosis of ocular myasthenia in Korea: a retrospective multicenter analysis of 202\u00a0patients","volume":"273","author":"Hong","year":"2008","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.neurol.2010.08.004_bib0110","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1212\/WNL.43.5.983","article-title":"The \u201cembrynonic\u201d gamma subunit of the nicotinic acetylcholine receptor is expressed in adult extra-ocular muscle","volume":"43","author":"Horton","year":"1993","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2010.08.004_bib0115","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1136\/bjo.2004.063404","article-title":"Ocular motor dysfunction and ptosis in ocular myasthenia gravis: effects of treatment","volume":"89","author":"Kupersmith","year":"2005","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.neurol.2010.08.004_bib0120","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1001\/archneur.60.2.243","article-title":"Development of generalized disease at 2\u00a0years in patients with ocular myasthenia gravis","volume":"60","author":"Kupersmith","year":"2003","journal-title":"Arch Neurol"},{"key":"10.1016\/j.neurol.2010.08.004_bib0125","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1007\/s00415-009-5120-8","article-title":"Ocular myasthenia gravis: treatment successes and failures in patients with long-term follow-up","volume":"256","author":"Kupersmith","year":"2009","journal-title":"J Neurol"},{"key":"10.1016\/j.neurol.2010.08.004_bib0130","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1093\/brain\/123.4.665","article-title":"The incidence and lifetime prevalence of neurological disorders in a prospective community-based study in the UK","volume":"123","author":"MacDonald","year":"2000","journal-title":"Brain"},{"key":"10.1016\/j.neurol.2010.08.004_bib0135","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1196\/annals.1254.054","article-title":"Myasthenia gravis (MG): epidemiological data and prognostic factors","volume":"998","author":"Mantegazza","year":"2003","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.neurol.2010.08.004_bib0140","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1097\/00041327-200312000-00002","article-title":"Immunotherapy of ocular myasthenia gravis reduces conversion to generalized myasthenia gravis","volume":"23","author":"Mee","year":"2003","journal-title":"J Neuro-Ophtalmol"},{"key":"10.1016\/j.neurol.2010.08.004_bib0145","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jns.2003.08.017","article-title":"The effect of prednisone on the progression from ocular to generalized myasthenia gravis","volume":"217","author":"Monsul","year":"2004","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.neurol.2010.08.004_bib0150","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1111\/j.1749-6632.1987.tb51393.x","article-title":"Myasthenia gravis: antibodies to endplate of human extraocular muscles","volume":"505","author":"Oda","year":"1987","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.neurol.2010.08.004_bib0155","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1111\/j.1749-6632.1993.tb22889.x","article-title":"Differences in acetylcholine receptor antibody interactions between extraocular and extremity muscle fibers","volume":"681","author":"Oda","year":"1993","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.neurol.2010.08.004_bib0160","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/0022-510X(83)90096-5","article-title":"The TH. Anti-acetylcholine receptor antibodies in myasthenia gravis. Part\u00a02. Clinical and serological follow-up of individual patients","volume":"58","author":"Oosterhuis","year":"1983","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.neurol.2010.08.004_bib0165","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1136\/jnnp.52.10.1121","article-title":"The natural course of myasthenia gravis","volume":"52","author":"Oosterhuis","year":"1989","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.neurol.2010.08.004_bib0170","series-title":"Mysathenia gravis","author":"Oosterhuis","year":"1997"},{"key":"10.1016\/j.neurol.2010.08.004_bib0175","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1001\/jama.1956.02960380001001","article-title":"Studies in myasthenia gravis-a rapid diagnostic test","volume":"160","author":"Osserman","year":"1956","journal-title":"JAMA"},{"key":"10.1016\/j.neurol.2010.08.004_bib0180","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1055\/s-2003-40755","article-title":"The edrophonium test","volume":"23","author":"Pascuzzi","year":"2003","journal-title":"Semin Neurol"},{"key":"10.1016\/j.neurol.2010.08.004_bib0185","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jneuroim.2009.11.004","article-title":"Anti-acetylcholinesterase antibodies associate with ocular myasthenia gravis","volume":"218","author":"Provenzano","year":"2010","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.neurol.2010.08.004_bib0190","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0002-9394(69)90003-8","article-title":"Lancaster red-green test in evaluation of edrophonium effect in myasthenia gravis","volume":"67","author":"Retzlaff","year":"1969","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.neurol.2010.08.004_bib0195","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1002\/mus.10141","article-title":"Clinical impact of single-fiber electromyography","volume":"11","author":"Sanders","year":"2002","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.neurol.2010.08.004_bib0200","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1212\/01.wnl.0000312374.95186.cc","article-title":"An international, phase\u00a0III, randomized trial of mycophenolate mofetil in myasthenia gravis","volume":"71","author":"Sanders","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2010.08.004_bib0205","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1136\/jnnp.48.4.332","article-title":"Thymectomy in myasthenia with pure ocular symptoms","volume":"48","author":"Schumm","year":"1985","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.neurol.2010.08.004_bib0210","first-page":"202","article-title":"Extraocular susceptibility to myasthenia gravis. Unique immunological environment?","volume":"132","author":"Soltys","year":"2008","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.neurol.2010.08.004_bib0215","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1136\/jnnp.62.2.156","article-title":"Ocular myasthenia gravis: response to long-term immunosuppressive treatment","volume":"62","author":"Sommer","year":"1997","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.neurol.2010.08.004_bib0220","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1212\/01.wnl.0000312373.67493.7f","article-title":"A trial of mycophenolate mofetil with prednisone as initial immunotherapy of myasthenia gravis","volume":"71","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2010.08.004_bib0225","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1212\/WNL.39.10.1359","article-title":"Diagnostic significance of IgG. C3, and C9\u00a0at the limb muscle motor end-plate in minimal myasthenia gravis","volume":"39","author":"Tsujihata","year":"1989","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2010.08.004_bib0230","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.neurol.2009.01.004","article-title":"Int\u00e9r\u00eat de l\u2019\u00e9lectromyographie dans le diagnostic et le suivi des myasth\u00e9nies","volume":"165","author":"Vial","year":"2009","journal-title":"Rev Neurol"},{"key":"10.1016\/j.neurol.2010.08.004_bib0235","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1196\/annals.1405.020","article-title":"Myasthenia gravis seronegative for acetylcholine receptor antibodies","volume":"1132","author":"Vincent","year":"2008","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.neurol.2010.08.004_bib0240","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1212\/WNL.50.4.1045","article-title":"T-cell recognition of muscle acetylcholine receptor subunits in generalized and ocular myasthenia gravis","volume":"50","author":"Wang","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2010.08.004_bib0245","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S0301-0082(00)00055-1","article-title":"Safety factor at the neuromuscular junction","volume":"64","author":"Wood","year":"2001","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.neurol.2010.08.004_bib0250","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1002\/mus.21440","article-title":"Safety of influenza vaccination in patients with myasthenia gravis: a population-based study","volume":"40","author":"Zinman","year":"2009","journal-title":"Muscle Nerve"}],"container-title":["Revue Neurologique"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S003537871000411X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S003537871000411X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,6]],"date-time":"2018-12-06T16:29:00Z","timestamp":1544113740000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S003537871000411X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12]]},"references-count":50,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["S003537871000411X"],"URL":"https:\/\/doi.org\/10.1016\/j.neurol.2010.08.004","relation":{},"ISSN":["0035-3787"],"issn-type":[{"value":"0035-3787","type":"print"}],"subject":[],"published":{"date-parts":[[2010,12]]}}}